72 related articles for article (PubMed ID: 22659566)
21. Increased excitability and reduced GABAergic levels in somatosensory cortex under chronic spinal cord injury.
Alonso-Calviño E; Fernández-López E; Zaforas M; Rosa JM; Aguilar J
Exp Neurol; 2023 Nov; 369():114504. PubMed ID: 37591355
[TBL] [Abstract][Full Text] [Related]
22. Mapping of the Spinal Sensorimotor Network by Transvertebral and Transcutaneous Spinal Cord Stimulation.
Shkorbatova P; Lyakhovetskii V; Pavlova N; Popov A; Bazhenova E; Kalinina D; Gorskii O; Musienko P
Front Syst Neurosci; 2020; 14():555593. PubMed ID: 33162882
[TBL] [Abstract][Full Text] [Related]
23. Transcutaneous spinal stimulation provides characterization of neurological status in individuals with tetraplegia.
Oh J; Scheffler MS; Martin CA; Dinh J; Sheynin J; Steele AG; Sayenko DG
Res Sq; 2023 Nov; ():. PubMed ID: 37986790
[TBL] [Abstract][Full Text] [Related]
24. Omega-3 fatty acids and traumatic neurological injury: from neuroprotection to neuroplasticity?
Michael-Titus AT; Priestley JV
Trends Neurosci; 2014 Jan; 37(1):30-8. PubMed ID: 24268818
[TBL] [Abstract][Full Text] [Related]
25. Advancements in neuroregenerative and neuroprotective therapies for traumatic spinal cord injury.
Fischer G; Bättig L; Stienen MN; Curt A; Fehlings MG; Hejrati N
Front Neurosci; 2024; 18():1372920. PubMed ID: 38812974
[TBL] [Abstract][Full Text] [Related]
26. Erythropoietin alleviates astrocyte pyroptosis by targeting the miR-325-3p/Gsdmd axis in rat spinal cord injury.
Shan W; Wang J; Cheng R; Xuan Y; Yin Z
Inflammopharmacology; 2024 Feb; 32(1):523-536. PubMed ID: 37578618
[TBL] [Abstract][Full Text] [Related]
27. Neurotrophic Factors as Regenerative Therapy for Neurodegenerative Diseases: Current Status, Challenges and Future Perspectives.
El Ouaamari Y; Van den Bos J; Willekens B; Cools N; Wens I
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835277
[TBL] [Abstract][Full Text] [Related]
28. Elucidating the Pivotal Neuroimmunomodulation of Stem Cells in Spinal Cord Injury Repair.
Richard SA; Sackey M
Stem Cells Int; 2021; 2021():9230866. PubMed ID: 34341666
[TBL] [Abstract][Full Text] [Related]
29. Endocrine Therapy for the Functional Recovery of Spinal Cord Injury.
Wang H; Zhou WX; Huang JF; Zheng XQ; Tian HJ; Wang B; Fu WL; Wu AM
Front Neurosci; 2020; 14():590570. PubMed ID: 33390881
[TBL] [Abstract][Full Text] [Related]
30. Erythropoietin as a Neuroprotective Molecule: An Overview of Its Therapeutic Potential in Neurodegenerative Diseases.
Rey F; Balsari A; Giallongo T; Ottolenghi S; Di Giulio AM; Samaja M; Carelli S
ASN Neuro; 2019; 11():1759091419871420. PubMed ID: 31450955
[TBL] [Abstract][Full Text] [Related]
31. Novel approach to an early assessment of a patient's potential for neurological remission after acute spinal cord injury: Analysis of hemoglobin concentration dynamics.
Biglari B; Heller RA; Hörner M; Sperl A; Bock T; Reible B; Haubruck P; Grützner PA; Moghaddam A
J Spinal Cord Med; 2021 Mar; 44(2):229-240. PubMed ID: 31211658
[No Abstract] [Full Text] [Related]
32. Intranasal erythropoietin ameliorates neurological function impairments and neural pathology in mice with chronic alcoholism by regulating autophagy‑related Nrf2 degradation.
Nie X; Wang W; Wang Q; Zhu D; Song H
Mol Med Rep; 2019 Feb; 19(2):1139-1149. PubMed ID: 30535439
[TBL] [Abstract][Full Text] [Related]
33. Regulation of Inflammatory Cytokines for Spinal Cord Injury Repair Through Local Delivery of Therapeutic Agents.
Ren H; Chen X; Tian M; Zhou J; Ouyang H; Zhang Z
Adv Sci (Weinh); 2018 Nov; 5(11):1800529. PubMed ID: 30479916
[TBL] [Abstract][Full Text] [Related]
34. EPO-releasing neural precursor cells promote axonal regeneration and recovery of function in spinal cord traumatic injury.
Carelli S; Giallongo T; Gombalova Z; Merli D; Di Giulio AM; Gorio A
Restor Neurol Neurosci; 2017; 35(6):583-599. PubMed ID: 29172009
[TBL] [Abstract][Full Text] [Related]
35. Tolerability and efficacy of erythropoietin (EPO) treatment in traumatic spinal cord injury: a preliminary randomized comparative trial vs. methylprednisolone (MP).
Costa DD; Beghi E; Carignano P; Pagliacci C; Faccioli F; Pupillo E; Messina P; Gorio A; Redaelli T
Neurol Sci; 2015 Sep; 36(9):1567-74. PubMed ID: 25820146
[TBL] [Abstract][Full Text] [Related]
36. Erythropoietin action in stress response, tissue maintenance and metabolism.
Zhang Y; Wang L; Dey S; Alnaeeli M; Suresh S; Rogers H; Teng R; Noguchi CT
Int J Mol Sci; 2014 Jun; 15(6):10296-333. PubMed ID: 24918289
[TBL] [Abstract][Full Text] [Related]
37. Multi-modal assessment of long-term erythropoietin treatment after neonatal hypoxic-ischemic injury in rat brain.
van de Looij Y; Chatagner A; Quairiaux C; Gruetter R; Hüppi PS; Sizonenko SV
PLoS One; 2014; 9(4):e95643. PubMed ID: 24755676
[TBL] [Abstract][Full Text] [Related]
38. Erythropoietin effect on sensorimotor recovery after contusive spinal cord injury: an electrophysiological study in rats.
Cerri G; Montagna M; Madaschi L; Merli D; Borroni P; Baldissera F; Gorio A
Neuroscience; 2012 Sep; 219():290-301. PubMed ID: 22659566
[TBL] [Abstract][Full Text] [Related]
39. Delayed granulocyte colony-stimulating factor treatment promotes functional recovery in rats with severe contusive spinal cord injury.
Lee JS; Yang CC; Kuo YM; Sze CI; Hsu JY; Huang YH; Tzeng SF; Tsai CL; Chen HH; Jou IM
Spine (Phila Pa 1976); 2012 Jan; 37(1):10-7. PubMed ID: 22024901
[TBL] [Abstract][Full Text] [Related]
40. Effect of combined treatment with melatonin and methylprednisolone on neurological recovery after experimental spinal cord injury.
Cayli SR; Kocak A; Yilmaz U; Tekiner A; Erbil M; Ozturk C; Batcioglu K; Yologlu S
Eur Spine J; 2004 Dec; 13(8):724-32. PubMed ID: 15232723
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
